Global Health Innovative Technology Fund Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2016
NCT02661373
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Global Fund | Global Health Innovative Technology Fund